{"SLR NAME":"Laboratory analysis and outcome for patients with COVID-19; a systematic review and meta-analysis","References":[{"title1":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Chinese management guideline for COVID-19 (version 6.0)","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"}]},{"title2":"Exacerbated innate host response to SARS-CoV in aged non-human primates","References":[{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"}]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"}]},{"title2":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","References":[]},{"title2":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network","References":[]},{"title2":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study","References":[]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"}]},{"title2":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","References":[]},{"title2":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","References":[]},{"title2":"Risk of myocardial infarction and stroke after acute infection or vaccination","References":[]},{"title2":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","References":[]},{"title2":"Cardiovascular complications of acute respiratory infections: current research and future directions","References":[]},{"title2":"Regulation of ACE2 in cardiac myocytes and fibroblasts","References":[]},{"title2":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"}]},{"title2":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase","References":[{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"}]},{"title2":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","References":[{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"}]}]},{"title1":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title2":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Published January 28, 2020. Accessed January 31, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected","References":[]},{"title2":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","References":[]},{"title2":"Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score","References":[]},{"title2":"Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)","References":[]},{"title2":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury","References":[{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"},{"title3":"Mechanisms%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-induced%20acute%20lung%20injury"}]},{"title2":"Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis","References":[{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"},{"title3":"Plasminogen%20controls%20inflammation%20and%20pathogenesis%20of%20influenza%20virus%20infections%20via%20fibrinolysis"}]}]},{"title1":"Platelet?to?lymphocyte ratio is associated with prognosis in patients with coronavirus disease?19","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing","References":[]},{"title2":"Potential antiviral therapeutics for 2019 novel coronavirus","References":[]},{"title2":"Which lessons shall we learn from the 2019 novel coronavirus outbreak?","References":[]},{"title2":"The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019","References":[{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"},{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"},{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"},{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"},{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"},{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"},{"title3":"The%20course%20of%20clinical%20diagnosis%20and%20treatment%20of%20a%20case%20infected%20with%20coronavirus%20disease%202019"}]},{"title2":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications of virus origins and receptor binding","References":[]},{"title2":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses","References":[{"title3":"Virus%20against%20virus:%20a%20potential%20treatment%20for%202019-nCov%20(SARS-CoV-2)%20and%20other%20RNA%20viruses"},{"title3":"Virus%20against%20virus:%20a%20potential%20treatment%20for%202019-nCov%20(SARS-CoV-2)%20and%20other%20RNA%20viruses"},{"title3":"Virus%20against%20virus:%20a%20potential%20treatment%20for%202019-nCov%20(SARS-CoV-2)%20and%20other%20RNA%20viruses"}]},{"title2":"Potentbinding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific humanmonoclonal antibody","References":[{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"},{"title3":"Potentbinding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20humanmonoclonal%20antibody"}]},{"title2":"The effect of SARS coronavirus on blood system:its clinical findings and the pathophysiologichypothesis","References":[]},{"title2":"Platelets in inflammation and infection","References":[]},{"title2":"Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation","References":[]},{"title2":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)","References":[{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"},{"title3":"Role%20of%20vascular%20cell%20adhesion%20molecules%20and%20leukocyte%20apoptosis%20in%20the%20lymphopenia%20and%20thrombocytopenia%20of%20patients%20with%20severe%20acute%20respiratory%20syndrome%20(SARS)"}]},{"title2":"SARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms","References":[]},{"title2":"In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells","References":[]},{"title2":"Cytokine control of megakaryopoiesis","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia","References":[]},{"title2":"Inactivation of three emerging viruses severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light","References":[{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"},{"title3":"Inactivation%20of%20three%20emerging%20viruses%20severe%20acute%20respiratory%20syndrome%20coronavirus,%20Crimean-Congo%20haemorrhagic%20fever%20virus%20and%20Nipah%20virus%20-%20in%20platelet%20concentrates%20by%20ultraviolet%20C%20light%20and%20in%20plasma%20by%20methylene%20blue%20plus%20visible%20light"}]},{"title2":"Proteomic analysis reveals platelet factor 4 and beta-thromboglobulin as prognostic markers in severe acute respiratory syndrome","References":[]},{"title2":"Analysis of the level of selected parameters of inflammation,circulating immune complexes,and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases","References":[{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"},{"title3":"Analysis%20of%20the%20level%20of%20selected%20parameters%20of%20inflammation,circulating%20immune%20complexes,and%20related%20indicators%20(neutrophil/lymphocyte,%20platelet/lymphocyte,%20CRP/CIC)%20in%20patients%20with%20obstructive%20diseases"}]},{"title2":"Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J]","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,China[J]"}]},{"title2":"Inflammatory impact of IFN-gamma in CD8+T cellmediated lung injury is mediated by both Stat1-dependent and-independent pathways","References":[]},{"title2":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","References":[{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"},{"title3":"The%20reproductive%20number%20of%20COVID-19%20is%20higher%20compared%20to%20SARS%20coronavirus"}]},{"title2":"Host response to influenza virus: protection versus immunopathology","References":[{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"},{"title3":"Host%20response%20to%20influenza%20virus:%20protection%20versus%20immunopathology"}]},{"title2":"Cancer patients in SARS-CoV-2 infection:a nationwide analysis in China","References":[{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"},{"title3":"Cancer%20patients%20in%20SARS-CoV-2%20infection:a%20nationwide%20analysis%20in%20China"}]},{"title2":"Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan","References":[{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"},{"title3":"Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"The dual role of platelet-innate immune cell interactions in thrombo-inflammation","References":[{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"},{"title3":"The%20dual%20role%20of%20platelet-innate%20immune%20cell%20interactions%20in%20thrombo-inflammation"}]},{"title2":"Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia","References":[]},{"title2":"Emerging novel Coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments","References":[{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"},{"title3":"Emerging%20novel%20Coronavirus%20(2019-nCoV)-current%20scenario,%20evolutionary%20perspective%20based%20on%20genome%20analysis%20and%20recent%20developments"}]},{"title2":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV","References":[{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"},{"title3":"Overlapping%20and%20discrete%20aspects%20of%20the%20pathology%20and%20pathogenesis%20of%20the%20emerging%20human%20pathogenic%20coronaviruses%20SARS-CoV,%20MERS-CoV,%20and%202019-nCoV"}]}]},{"title1":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20with%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","References":[{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"},{"title3":"Newly%20discovered%20coronavirus%20as%20the%20primary%20cause%20of%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Novel coronavirus - China","References":[]},{"title2":"Novel coronavirus - Thailand (ex-China)","References":[{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Thailand%20(ex-China)"}]},{"title2":"Novel coronavirus - Japan (ex-China)","References":[{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Japan%20(ex-China)"}]},{"title2":"Novel coronavirus - Republic of Korea (ex-China)","References":[{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"},{"title3":"Novel%20coronavirus%20-%20Republic%20of%20Korea%20(ex-China)"}]},{"title2":"First travel-related case of 2019 novel coronavirus detected in United States","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020","References":[{"title3":"A%20novel%20coronavirus%20genome%20identified%20in%20a%20cluster%20of%20pneumonia%20cases%20:%20Wuhan,%20China%202019-2020"},{"title3":"A%20novel%20coronavirus%20genome%20identified%20in%20a%20cluster%20of%20pneumonia%20cases%20:%20Wuhan,%20China%202019-2020"},{"title3":"A%20novel%20coronavirus%20genome%20identified%20in%20a%20cluster%20of%20pneumonia%20cases%20:%20Wuhan,%20China%202019-2020"}]},{"title2":"Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"CDC definitions for nosocomial infections, 1988","References":[]},{"title2":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus","References":[{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"},{"title3":"Association%20between%20cardiac%20injury%20and%20mortality%20in%20hospitalized%20patients%20infected%20with%20avian%20influenza%20A%20(H7N9)%20virus"}]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"},{"title3":"Coronaviruses%20post-SARS:%20update%20on%20replication%20and%20pathogenesis"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"},{"title3":"MERS-CoV%20infection%20in%20humans%20is%20associated%20with%20a%20pro-inflammatory%20Th1%20and%20Th17%20cytokine%20profile"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"}]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","References":[{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"},{"title3":"Treatment%20of%20Middle%20East%20respiratory%20syndrome%20with%20a%20combination%20of%20lopinavir-ritonavir%20and%20interferon-beta1b%20(MIRACLE%20trial):%20study%20protocol%20for%20a%20randomized%20controlled%20trial"}]},{"title2":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","References":[{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"},{"title3":"Broad-spectrum%20antiviral%20GS-5734%20inhibits%20both%20epidemic%20and%20zoonotic%20coronaviruses"}]},{"title2":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","References":[{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"},{"title3":"Comparative%20therapeutic%20efficacy%20of%20remdesivir%20and%20combination%20lopinavir,%20ritonavir,%20and%20interferon%20beta%20against%20MERS-CoV"}]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"},{"title3":"Origin%20and%20evolution%20of%20pathogenic%20coronaviruses"}]},{"title2":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","References":[{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"},{"title3":"Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor"}]},{"title2":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting","References":[{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"},{"title3":"Bats%20as%20animal%20reservoirs%20for%20the%20SARS%20coronavirus:%20hypothesis%20proved%20after%2010%20years%20of%20virus%20hunting"}]}]},{"title1":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title2":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"}]},{"title2":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","References":[]},{"title2":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","References":[]},{"title2":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","References":[]},{"title2":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease","References":[]},{"title2":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients","References":[{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"},{"title3":"Angiotensin%20II%20plasma%20levels%20are%20linked%20to%20disease%20severity%20and%20predict%20fatal%20outcomes%20in%20H7N9-infected%20patients"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"}]},{"title2":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome","References":[]},{"title2":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients","References":[{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"},{"title3":"Predictive%20factors%20for%20pneumonia%20development%20and%20progression%20to%20respiratory%20failure%20in%20MERS-CoV%20infected%20patients"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"}]},{"title2":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort","References":[{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"},{"title3":"Incidence%20and%20risk%20of%20chronic%20obstructive%20pulmonary%20disease%20in%20a%20Korean%20community-based%20cohort"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis","References":[]},{"title2":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever","References":[{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"},{"title3":"Clinical%20and%20laboratory%20features%20of%20severe%20acute%20respiratory%20syndrome%20vis-a-vis%20onset%20of%20fever"}]},{"title2":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes","References":[]},{"title2":"An expanded definition of the adult respiratory distress syndrome","References":[]},{"title2":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice","References":[{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"},{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"},{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"},{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"},{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"},{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"},{"title3":"A%20novel%20human%20mAb%20(MERS-GD27)%20provides%20prophylactic%20and%20postexposure%20efficacy%20in%20MERS-CoV%20susceptible%20mice"}]},{"title2":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure","References":[]},{"title2":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020","References":[{"title3":"A%20novel%20coronavirus%20genome%20identified%20in%20a%20cluster%20of%20pneumonia%20cases%20Wuhan,%20China%202019-2020"},{"title3":"A%20novel%20coronavirus%20genome%20identified%20in%20a%20cluster%20of%20pneumonia%20cases%20Wuhan,%20China%202019-2020"},{"title3":"A%20novel%20coronavirus%20genome%20identified%20in%20a%20cluster%20of%20pneumonia%20cases%20Wuhan,%20China%202019-2020"}]},{"title2":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","References":[{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"},{"title3":"Angiotensin%20blockade%20in%20late%20autosomal%20dominant%20polycystic%20kidney%20disease"}]},{"title2":"Hypoalbuminemia in acute illness: is there a rationale for intervention?","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"}]},{"title2":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse","References":[{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"},{"title3":"Angiotensin%20II%20receptor%20blocker%20as%20a%20novel%20therapy%20in%20acute%20lung%20injury%20induced%20by%20avian%20influenza%20A%20H5N1%20virus%20infection%20in%20mouse"}]},{"title2":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings","References":[]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20Coronavirus%20from%20Patients%20with%20Pneumonia%20in%20China,%202019"}]},{"title2":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","References":[{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20lethal%20avian%20influenza%20A%20H5N1%20infections"}]}]}]}